International perspectives on when to utilize transarterial radioembolization to increase the likelihood of curative outcomes ...

Hepatocellular carcinoma (HCC) is one of the most fatal malignancies. Epigenetic mechanisms have revealed that noncoding RNAs, such as microRNAs (miRNAs) and circular RNAs (circRNAs), are involved ...

NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced today that Jeffrey A. Meckler, Chief Executive Officer, will present at two upcoming investor ...

Decoy product candidates represent an antigen-agnostic technology that have produced single-agent activity against metastatic pancreatic and orthotopic colorectal carcinomas, single agent eradication ...

Background To determine clinical-pathologic variables in patients with a new diagnosis of hepatocellular carcinoma (HCC) and underlying hepatitis B vs. C infection. Methods Patients presenting to ...

Macrovascular invasion (MVI) in patients with hepatocellular carcinoma (HCC) is associated with poor prognosis and limited therapeutic options. Here the authors report the results of a phase 2 ...

You will be able to get a quick price and instant permission to reuse the content in many different ways. This document, on the diagnosis and treatment of patients with hepatocellular carcinoma (HCC), ...

As the first SPORE of its kind in the United States, the Mayo Clinic Hepatobiliary SPORE is devoted to improving the diagnosis and treatment of liver cancer (hepatocellular carcinoma ... lethal cancer ...

as well as combination-mediated eradication of established hepatocellular carcinomas, pancreatic and non-Hodgkin’s lymphomas in standard pre-clinical models, including syngeneic mouse tumors and ...

The liver is an immunoprivileged organ with resistance against immune responses. An increasing number of basic research studies suggest that the immune system is heavily involved in various causes of ...

J Nucl Med. 2016;57:1020-1026. doi: 10.2967/jnumed.115.163444 6. Garin E, Tselikas L, Guiu B, et al. Long-term overall survival after selective internal radiation therapy for locally advanced ...